Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon

Detalhes bibliográficos
Autor(a) principal: Andrade, Bruno B.
Data de Publicação: 2009
Outros Autores: Rocha, Bruno Coelho, Reis-Filho, Antonio, Camargo, Luis Marcelo Aranha, Tadei, Wanderli Pedro, Moreira, Luciano Andrade, Barral, Aldina Maria Prado, Barral-Netto, M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional do INPA
Texto Completo: https://repositorio.inpa.gov.br/handle/1/16305
Resumo: Background. Despite governmental and private efforts on providing malaria control, this disease continues to be a major health threat. Thus, innovative strategies are needed to reduce disease burden. The malaria vectors, through the injection of saliva into the host skin, play important role on disease transmission and may influence malaria morbidity. This study describes the humoral immune response against Anopheles (An.) darlingi saliva in volunteers from the Brazilian Amazon and addresses the association between levels of specific antibodies and clinical presentation of Plasmodium (P.) vivax infection. Methods. Adult volunteers from communities in the Rondônia State, Brazil, were screened in order to assess the presence of P. vivax infection by light microscopy and nested PCR. Non-infected volunteers and individuals with symptomatic or symptomless infection were randomly selected and plasma collected. An. darlingi salivary gland sonicates (SGS) were prepared and used to measure anti-saliva antibody levels. Plasma interleukin (IL)-10 and interferon (IFN)- levels were also estimated and correlated to anti-SGS levels. Results. Individuals infected with P. vivax presented higher levels of anti-SGS than non-infected individuals and antibody levels could discriminate infection. Furthermore, anti-saliva antibody measurement was also useful to distinguish asymptomatic infection from non-infection, with a high likelihood ratio. Interestingly, individuals with asymptomatic parasitaemia presented higher titers of anti-SGS and lower IFN-/IL-10 ratio than symptomatic ones. In P. vivax-infected asymptomatic individuals, the IFN-/IL-10 ratio was inversely correlated to anti-SGS titers, although not for while in symptomatic volunteers. Conclusion. The estimation of anti-An. darlingi antibody levels can indicate the probable P. vivax infection status and also could serve as a marker of disease severity in this region of Brazilian Amazon. © 2009 Andrade et al; licensee BioMed Central Ltd.
id INPA-2_efe825cae9247df3ea36cf4989c04bb3
oai_identifier_str oai:repositorio:1/16305
network_acronym_str INPA-2
network_name_str Repositório Institucional do INPA
repository_id_str
spelling Andrade, Bruno B.Rocha, Bruno CoelhoReis-Filho, AntonioCamargo, Luis Marcelo AranhaTadei, Wanderli PedroMoreira, Luciano AndradeBarral, Aldina Maria PradoBarral-Netto, M.2020-06-03T19:27:18Z2020-06-03T19:27:18Z2009https://repositorio.inpa.gov.br/handle/1/1630510.1186/1475-2875-8-121Background. Despite governmental and private efforts on providing malaria control, this disease continues to be a major health threat. Thus, innovative strategies are needed to reduce disease burden. The malaria vectors, through the injection of saliva into the host skin, play important role on disease transmission and may influence malaria morbidity. This study describes the humoral immune response against Anopheles (An.) darlingi saliva in volunteers from the Brazilian Amazon and addresses the association between levels of specific antibodies and clinical presentation of Plasmodium (P.) vivax infection. Methods. Adult volunteers from communities in the Rondônia State, Brazil, were screened in order to assess the presence of P. vivax infection by light microscopy and nested PCR. Non-infected volunteers and individuals with symptomatic or symptomless infection were randomly selected and plasma collected. An. darlingi salivary gland sonicates (SGS) were prepared and used to measure anti-saliva antibody levels. Plasma interleukin (IL)-10 and interferon (IFN)- levels were also estimated and correlated to anti-SGS levels. Results. Individuals infected with P. vivax presented higher levels of anti-SGS than non-infected individuals and antibody levels could discriminate infection. Furthermore, anti-saliva antibody measurement was also useful to distinguish asymptomatic infection from non-infection, with a high likelihood ratio. Interestingly, individuals with asymptomatic parasitaemia presented higher titers of anti-SGS and lower IFN-/IL-10 ratio than symptomatic ones. In P. vivax-infected asymptomatic individuals, the IFN-/IL-10 ratio was inversely correlated to anti-SGS titers, although not for while in symptomatic volunteers. Conclusion. The estimation of anti-An. darlingi antibody levels can indicate the probable P. vivax infection status and also could serve as a marker of disease severity in this region of Brazilian Amazon. © 2009 Andrade et al; licensee BioMed Central Ltd.Volume 8, Número 1Attribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccessDarlingi Saliva Gland Sonicate AntibodyGamma InterferonInterleukin-10Protozoon AntibodyUnclassified DrugAntibodyBiological MarkerGamma InterferonInsect ProteinsInterleukin-10AdultAntibody Blood LevelAntibody TiterBlood SamplingBrasilConcentration (parameters)Control GroupControlled StudyCytokine ProductionDisease SeverityFemaleHumanHumoral ImmunityImmunityMajor Clinical StudyMicroscopyParasitemiaPlasmodium VivaxPlasmodium Vivax MalariaPolymerase Chain ReactionScreeningAnimalsAnophelesBloodImmunologyMiddle AgedPlasmodium Vivax MalariaPrediction And ForecastingSalivaAdultAnimalAnophelesAntibodiesBiological MarkersBrasilFemaleHumansInsect ProteinsInterferon-gammaInterleukin-10Malaria, VivaxMiddle AgedPredictive Value Of TestsSalivaYoung AdultAnti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazoninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleMalaria Journalengreponame:Repositório Institucional do INPAinstname:Instituto Nacional de Pesquisas da Amazônia (INPA)instacron:INPAORIGINALartigo-inpa.pdfartigo-inpa.pdfapplication/pdf262208https://repositorio.inpa.gov.br/bitstream/1/16305/1/artigo-inpa.pdf4e0b2aa4ddabd6b20eb0f200ff54a629MD511/163052020-06-03 15:52:35.186oai:repositorio:1/16305Repositório de PublicaçõesPUBhttps://repositorio.inpa.gov.br/oai/requestopendoar:2020-06-03T19:52:35Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)false
dc.title.en.fl_str_mv Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
title Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
spellingShingle Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
Andrade, Bruno B.
Darlingi Saliva Gland Sonicate Antibody
Gamma Interferon
Interleukin-10
Protozoon Antibody
Unclassified Drug
Antibody
Biological Marker
Gamma Interferon
Insect Proteins
Interleukin-10
Adult
Antibody Blood Level
Antibody Titer
Blood Sampling
Brasil
Concentration (parameters)
Control Group
Controlled Study
Cytokine Production
Disease Severity
Female
Human
Humoral Immunity
Immunity
Major Clinical Study
Microscopy
Parasitemia
Plasmodium Vivax
Plasmodium Vivax Malaria
Polymerase Chain Reaction
Screening
Animals
Anopheles
Blood
Immunology
Middle Aged
Plasmodium Vivax Malaria
Prediction And Forecasting
Saliva
Adult
Animal
Anopheles
Antibodies
Biological Markers
Brasil
Female
Humans
Insect Proteins
Interferon-gamma
Interleukin-10
Malaria, Vivax
Middle Aged
Predictive Value Of Tests
Saliva
Young Adult
title_short Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
title_full Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
title_fullStr Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
title_full_unstemmed Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
title_sort Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
author Andrade, Bruno B.
author_facet Andrade, Bruno B.
Rocha, Bruno Coelho
Reis-Filho, Antonio
Camargo, Luis Marcelo Aranha
Tadei, Wanderli Pedro
Moreira, Luciano Andrade
Barral, Aldina Maria Prado
Barral-Netto, M.
author_role author
author2 Rocha, Bruno Coelho
Reis-Filho, Antonio
Camargo, Luis Marcelo Aranha
Tadei, Wanderli Pedro
Moreira, Luciano Andrade
Barral, Aldina Maria Prado
Barral-Netto, M.
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Andrade, Bruno B.
Rocha, Bruno Coelho
Reis-Filho, Antonio
Camargo, Luis Marcelo Aranha
Tadei, Wanderli Pedro
Moreira, Luciano Andrade
Barral, Aldina Maria Prado
Barral-Netto, M.
dc.subject.eng.fl_str_mv Darlingi Saliva Gland Sonicate Antibody
Gamma Interferon
Interleukin-10
Protozoon Antibody
Unclassified Drug
Antibody
Biological Marker
Gamma Interferon
Insect Proteins
Interleukin-10
Adult
Antibody Blood Level
Antibody Titer
Blood Sampling
Brasil
Concentration (parameters)
Control Group
Controlled Study
Cytokine Production
Disease Severity
Female
Human
Humoral Immunity
Immunity
Major Clinical Study
Microscopy
Parasitemia
Plasmodium Vivax
Plasmodium Vivax Malaria
Polymerase Chain Reaction
Screening
Animals
Anopheles
Blood
Immunology
Middle Aged
Plasmodium Vivax Malaria
Prediction And Forecasting
Saliva
Adult
Animal
Anopheles
Antibodies
Biological Markers
Brasil
Female
Humans
Insect Proteins
Interferon-gamma
Interleukin-10
Malaria, Vivax
Middle Aged
Predictive Value Of Tests
Saliva
Young Adult
topic Darlingi Saliva Gland Sonicate Antibody
Gamma Interferon
Interleukin-10
Protozoon Antibody
Unclassified Drug
Antibody
Biological Marker
Gamma Interferon
Insect Proteins
Interleukin-10
Adult
Antibody Blood Level
Antibody Titer
Blood Sampling
Brasil
Concentration (parameters)
Control Group
Controlled Study
Cytokine Production
Disease Severity
Female
Human
Humoral Immunity
Immunity
Major Clinical Study
Microscopy
Parasitemia
Plasmodium Vivax
Plasmodium Vivax Malaria
Polymerase Chain Reaction
Screening
Animals
Anopheles
Blood
Immunology
Middle Aged
Plasmodium Vivax Malaria
Prediction And Forecasting
Saliva
Adult
Animal
Anopheles
Antibodies
Biological Markers
Brasil
Female
Humans
Insect Proteins
Interferon-gamma
Interleukin-10
Malaria, Vivax
Middle Aged
Predictive Value Of Tests
Saliva
Young Adult
description Background. Despite governmental and private efforts on providing malaria control, this disease continues to be a major health threat. Thus, innovative strategies are needed to reduce disease burden. The malaria vectors, through the injection of saliva into the host skin, play important role on disease transmission and may influence malaria morbidity. This study describes the humoral immune response against Anopheles (An.) darlingi saliva in volunteers from the Brazilian Amazon and addresses the association between levels of specific antibodies and clinical presentation of Plasmodium (P.) vivax infection. Methods. Adult volunteers from communities in the Rondônia State, Brazil, were screened in order to assess the presence of P. vivax infection by light microscopy and nested PCR. Non-infected volunteers and individuals with symptomatic or symptomless infection were randomly selected and plasma collected. An. darlingi salivary gland sonicates (SGS) were prepared and used to measure anti-saliva antibody levels. Plasma interleukin (IL)-10 and interferon (IFN)- levels were also estimated and correlated to anti-SGS levels. Results. Individuals infected with P. vivax presented higher levels of anti-SGS than non-infected individuals and antibody levels could discriminate infection. Furthermore, anti-saliva antibody measurement was also useful to distinguish asymptomatic infection from non-infection, with a high likelihood ratio. Interestingly, individuals with asymptomatic parasitaemia presented higher titers of anti-SGS and lower IFN-/IL-10 ratio than symptomatic ones. In P. vivax-infected asymptomatic individuals, the IFN-/IL-10 ratio was inversely correlated to anti-SGS titers, although not for while in symptomatic volunteers. Conclusion. The estimation of anti-An. darlingi antibody levels can indicate the probable P. vivax infection status and also could serve as a marker of disease severity in this region of Brazilian Amazon. © 2009 Andrade et al; licensee BioMed Central Ltd.
publishDate 2009
dc.date.issued.fl_str_mv 2009
dc.date.accessioned.fl_str_mv 2020-06-03T19:27:18Z
dc.date.available.fl_str_mv 2020-06-03T19:27:18Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.inpa.gov.br/handle/1/16305
dc.identifier.doi.none.fl_str_mv 10.1186/1475-2875-8-121
url https://repositorio.inpa.gov.br/handle/1/16305
identifier_str_mv 10.1186/1475-2875-8-121
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Volume 8, Número 1
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Malaria Journal
publisher.none.fl_str_mv Malaria Journal
dc.source.none.fl_str_mv reponame:Repositório Institucional do INPA
instname:Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron:INPA
instname_str Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron_str INPA
institution INPA
reponame_str Repositório Institucional do INPA
collection Repositório Institucional do INPA
bitstream.url.fl_str_mv https://repositorio.inpa.gov.br/bitstream/1/16305/1/artigo-inpa.pdf
bitstream.checksum.fl_str_mv 4e0b2aa4ddabd6b20eb0f200ff54a629
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)
repository.mail.fl_str_mv
_version_ 1809928872231174144